BridgeBio Pharma (2CL.F) Q2 2024 Earnings

2MayConfirmed
Q4 2023
Q2 2024
-0.89
-0.65
-0.42
-0.19

Details

Expected EPS
-0.6867349281
Actual EPS
-0.18642000000000003
Surprise EPS
0.5
Surprise Percent
+72.85%

Description

BridgeBio Pharma (2CL.F) has reported earnings of -0.18642000000000003 per share for Q2 2024.

0 Comments

Share your thoughts